1 EXHIBIT 10.6 CLINICAL DEVELOPMENT AGREEMENT PROTOCOL #VIT-02-08961X AND PROTOCOL #VIT-03-08961X: Two Phase III Safety and Efficacy Studies of Vitrase(TM) (Hyaluronidase for Ophthalmic Intravitreal Injection) for Clearance of Severe Vitreous...

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!